Apple: Analysts Anticipate Q4 Revenues Of $84.85 Billion

Apple (NASDAQ: AAPL) will be reporting its fourth quarter financial results on October 27th after markets close. Analysts have a consensus $168.89 12-month price target on the company, via a total of 41 analysts, with 14 analysts having strong buy ratings. 20 analysts meanwhile have buy ratings and 7 have hold ratings on the company. The street high comes from Atlantic Equities with a $190 price target, and the lowest target sits at $132.

24 analysts have revenue estimates for the fourth quarter. The mean revenue estimate between all 24 analysts is $84.85 billion; this number has been revised upwards from $77.87 at the start of April. The highest revenue estimate is $89.28 billion, while the lowest is $77.65 billion.

Onto EBITDA estimates, there are currently 9 analysts who have fourth-quarter EBITDA estimates. The mean is currently $26.82 billion, with this number having been revised upwards from $22.21 billion at the start of April. The street high estimate currently sits at $29.20 billion in EBITDA and the lowest is $22.85 billion.

Analysts estimate that quarterly earnings per share will come in at $1.24, with this number being revised upwards from $0.98 at the start of April. Street high is $1.34 and the lowest estimate is $1.05 per share for the quarter.


Information for this briefing was found via Edgar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

First Majestic Q3 Earnings: Another RECORD Quarter!

Barrick Q3 Earnings: Juicing Shareholder Returns Amid Declining Production

Wheaton Q3 Earnings: Cash Operating Margins Skyrocket

Recommended

Altamira Gold Encounters Second Porphyry Body, Hitting 3.5 g/t Gold Over 8.0 Metres

Canadian Copper Set To Submit Environmental Impact Assessment In H1 2026 For Murray Brook

Related News

Cresco Labs: Stifel Slashes Price Target From $30 To $8 Following Poor Q4 Results

On March 23rd, Cresco Labs (CSE: CL) announced its fourth-quarter financial results, which disappointed many...

Friday, March 25, 2022, 03:39:00 PM

Canaccord Reiterates $0.00 Price Target On Medmen

Medmen Enterprises’ (CSE: MMEN) reported their fiscal third quarter 2021 financial results on May 11th...

Friday, May 14, 2021, 04:38:00 PM

GameStop: Consensus Estimates Point To Negative EBITDA For Q3

GameStop (NYSE: GME) will be reporting its third quarter financial results on December 8th after...

Wednesday, December 8, 2021, 10:12:00 AM

Canaccord Raises Greenlane Renewables Price Target To $2.75

Canaccord upgraded Greenlane Renewables (TSXV: GRN) from C$1.60 to C$2.75 and reiterated their speculative buy...

Friday, January 8, 2021, 11:53:00 AM

Canadian Cannabis: Canaccord Lifts Cronos Target, Reiterates Canopy Growth And Tilray Ratings

Yesterday Canaccord Genuity Capital Markets put out a second-quarter preview note on the top Canadian...

Thursday, July 28, 2022, 03:02:00 PM